NSE filing, NSE: SANDHAR. Summary written from the filing by ALFA Finder's alert engine.
Sandhar Technologies Ltd: key numbers
- Share price
- ₹469.65
- Market cap
- ₹2,827 Cr
- Revenue (annual)
- ₹4,852 Cr
- Net profit (annual)
- ₹198.7 Cr
- P/E (TTM)
- 13.6×Sector 30.9×
- Promoter holding
- 70.38%+0.00% QoQ
- FII holding
- 2.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandhar Technologies Ltd
All →Sandhar Technologies Board Meeting Date
Sandhar Technologies will hold a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window is closed from 01 Oct to 08 Nov 2026.
Sandhar Technologies Other Announcement
Sandhar Technologies Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, noting effects of recent amalgamations on promoter group holdings.
Sandhar Technologies Acquisition Worth ₹1.62 Cr
Sandhar Technologies completed a ₹1.62 Crore investment in Clean Renewable Energy HR 1B Private Limited by subscribing to equity shares.
- Value
- ₹1.62 Cr
Sandhar Technologies Annual General Meeting
Sandhar Technologies held its 34th Annual General Meeting on September 22, 2026, to discuss financials, dividend declaration, and various director re-appointments.
Sandhar Technologies Management Change
Shri Vijay Dahiya has resigned from his position as Senior Management Personnel at Sandhar Technologies Limited, effective September 3, 2026.
Sandhar Technologies Other Announcement
Sandhar Technologies sent physical letters to shareholders who haven't registered their email IDs, providing web-links for the upcoming 34th AGM and Annual Report.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.